Mirae Asset Global Investments Co., Ltd. Erasca, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$3.89 - $8.57 $190 - $419	49 Added 0.17%	29,704 $128,000
Q3 2022 Nov 10, 2022	BUY	$5.82 - $10.68 $48,131 - $88,323	8,270 Added 38.67%	29,655 $232,000
Q2 2022 Jul 26, 2022	BUY	$4.58 - $8.72 $97,943 - $186,477	21,385 New	21,385 $119,000

117

74.3M

7.1K

40.1K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $265M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.